InterMune (ITMN) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	-124.84M
Amortization and depreciation	1.54M
Stock-based compensation expense	9.49M
Net realized gains on sales of available for sale securities	1K
Deferred rent
Other	42K
Accounts receivable, net	-9.58M
Inventories	133K
Other assets	796K
Accounts payable and accrued compensation	-3.15M
Other accrued liabilities	9.45M
Deferred collaboration revenue
Net cash used in operating activities
Acquisition of product rights
Purchases of property and equipment	-1.25M
Purchases of available-for-sale securities	-259.33M
Sales of available-for-sale securities	0
Maturities of available-for-sale securities	103.17M
Net cash used in investing activities
Proceeds from issuance of common stock in a public offering, net of issuance costs
Proceeds from issuance of common stock under employee stock benefit plans
Net cash provided by financing activities
Net (decrease) increase in cash and cash equivalents	17.13M
Cash and cash equivalents at beginning of period	191.43M
Cash and cash equivalents at end of period	208.56M
Issuance of common stock in exchange for convertible debt

Entities mentioned with ITMN

View All Entities